Dr. Sami Diab MD Medical Oncologist

Dr. Sami Diab is a medical oncologist in Aurora, Colorado and is affiliated with multiple hospitals in the area, including Medical Center of Aurora and Parker Adventist Hospital. He received his medical degree from Damascus University Faculty of Medicine and has been in practice for 26 years. He is one of 2 doctors at Medical Center of Aurora and one of 2 at Parker Adventist Hospital who specialize in Medical Oncology.

Are you Dr. Diab? Claim/Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Medical Oncologist: General Oncology

Hospital Affiliation

Medical Center of Aurora
High performing in Cancer

Parker Adventist Hospital

Sky Ridge Medical Center

University of Colorado Hospital
Ranked #23 in Cancer

Education & Medical Training

Wayne State University School of Medicine
Residency, Internal Medicine, 1990–1993

University of Texas Health Science Center at San Antonio
Residency, Radiation Oncology, 1995–1996

University of Texas Health Science Center at San Antonio
Fellowship, Medical Oncology, 1994–1995

University of Texas at Houston
Fellowship, Medical Oncology, 1993–1994

Damascus University Faculty of Medicine
Class of 1988

Certifications & Licensure

American Board of Internal Medicine
Certified in Internal Medicine

American Board of Internal Medicine
Certified in Medical Oncology

American Board of Internal Medicine
Certified in Rheumatology

CO State Medical License
Active through 2015

MI State Medical License
Active through 2016

Awards, Honors & Recognition

Meaningful Use Stage 1 Certification, Centers for Medicare & Medicaid Services
2012

Top MD, Consumers Checkbook

Publications & Presentations

Sunitinib combined with pemetrexed and carboplatin in patients with advanced solid malignancies-results of a phase I dose-escalation study.
Blais, N.,Camidge, D. R.,Jonker, D. J.,Soulières, D.,Laurie, S. A.,Diab, S. G.,Ruiz-Garcia, A.,Thall, A.,Zhang, K.,Chao, R. C.,Chow, L. Q.

A phase I study of sunitinib combined with modified FOLFOX6 in patients with advanced solid tumors.
Leong, S., Eckhardt, S. G., Chan, E., Messersmith, W. A., Spratlin, J., Camidge, D. R., Diab, S., Khosravan, R., Lin, X., Chow Maneval, E., Lockhart, A. C.

A phase I study of sorafenib and vorinostat in patients with advanced solid tumors with expanded cohorts in renal cell carcinoma and non-small cell lung cancer.
Dasari, A., Gore, L., Messersmith, W. A., Diab, S., Jimeno, A., Weekes, C. D., Lewis, K. D., Drabkin, H. A., Flaig, T. W., Camidge, D. R.


Report a Correction — If you are aware of information on this page that is out of date or incorrect, please let us know.

Patient Advice & Support


See More
Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Nearby Medical Oncologists

See all Medical Oncologists near Aurora, CO See all Medical Oncologists in Colorado

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.